Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

What samples are being collected?

QUANTUM Biobank will prioritise the collection, storage and distribution of tissue samples as necessary to deliver approved research programmes. The Biobank will be divided into up to five ‘modules’ operating under the same over-arching QUANTUM protocol:  

  • Prostate 
  • Urothelial 
  • Kidney 
  • Testicular and Penile 
  • ProMPT Legacy

We will collect a small amount of whole fresh blood (for germline DNA), blood derivatives and urine from each prospective biobank participant, collecting serial samples wherever possible.

QUANTUM will accept a wide range of samples and data obtained from patients in Oxford, elsewhere in the UK and internationally (including countries outside the EEA):

Sample types: 

  1. Tissue from diagnostic investigations and surgical therapies
  2. Fresh blood and blood derivatives 
  3. Part processed samples (e.g. sections for extraction of DNA & RNA). 
  4. Constructed tissue micro-arrays (TMAs)
  5. Historical samples from ProMPT Study (MREC/01/4/061) 
  6. Sample collections from completed studies where consent for future research was given.
  7. Tissue from other Biobanks where appropriate consent was given.

QUANTUM staff will also collect and record medical and pathological data for linkage to research samples.